Takeda Pharmaceutical Co ADR (NYSE:TAK) shares, rose in value on Friday, February 14, with price down by -0.59% to the previous day’s close as strong demand from buyers drove the stock to $13.54.
Actively observing the price movement in the last trading, the stock closed the session at $13.62, falling within a range of $13.53 and $13.63. The value of beta (5-year monthly) was 0.456 whereas the PE ratio was 31.84 over 12-month period. Referring to stock’s 52-week performance, its high was $15.08, and the low was $12.57. On the whole, TAK has fluctuated by 3.36% over the past month.
With the market capitalization of Takeda Pharmaceutical Co ADR currently standing at about $42.93 billion, investors are eagerly awaiting this quarter’s results, scheduled for in March. The company’s Forward Dividend Ratio is 0.62, with its dividend yield at 4.57%.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 4.61T, with a low estimate of 1.06T and a high estimate of 1.16T. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 1.1T.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that TAK’s technical picture suggests that short-term indicators denote the stock is a 25% Sell on average. However, medium-term indicators have put the stock in the category of 50% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the PEG ratio is about 1.21, with the price of TAK currently trading nearly 1.69% and 1.71% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 55.21, while the 7-day volatility ratio is showing 0.88% which for the 30-day chart, stands at 1.09%. Furthermore, Takeda Pharmaceutical Co ADR (TAK)’s beta value is 0.52, and its average true range (ATR) is 0.20.
A comparison of Takeda Pharmaceutical Co ADR (TAK) with its peers suggests the former has fared considerably weaker in the market. TAK showed an intraday change of -0.59% in last session, and over the past year, it shrunk by -5.58%%.
Data on historical trading for Takeda Pharmaceutical Co ADR (NYSE:TAK) indicates that the trading volumes over the past 10 days have averaged 1.79 and over the past 3 months, they’ve averaged 1.89 million. According to company’s latest data on outstanding shares, there are 3.17 billion shares outstanding.
Nearly 0.02% of Takeda Pharmaceutical Co ADR’s shares belong to company insiders and institutional investors own 4.97% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 3.74 million shares as on 2025-01-31, resulting in a short ratio of 1.81. According to the data, the short interest in Takeda Pharmaceutical Co ADR (TAK) stood at 12.00 of shares outstanding as of 2025-01-31; the number of short shares registered in 2024-12-31 reached 4.91 million. The stock has risen by 2.27% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the TAK stock heading into the next quarter.
